14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

NVCN Predictions History

6 years ago
JS predicted that NVCN for 2018-03-22 is going $0.105 (-7.49%)

6 years ago
Puspendu.Banerjee.20499 predicted that NVCN for 2018-03-22 is going $0.140 (31.58%)

Rank:

6 years ago
JS predicted that NVCN for 2018-03-21 is going $0.104 (-2.26%)

6 years ago
chrissylynn19 predicted that NVCN for 2018-03-21 is going $0.253 (137.78%)

Rank:

6 years ago
Fayadosky predicted that NVCN for 2018-03-21 is going $0.180 (61.29%)

Rank:

6 years ago
JS predicted that NVCN for 2018-03-20 is going $0.119 (6.63%)

6 years ago
Sunny.Chyun.21972 predicted that NVCN for 2018-03-20 is going $0.113 (-9.16%)

Rank:

6 years ago
Sunny.Chyun.21972 predicted that NVCN for 2018-03-19 is going $0.107 (-19.91%)

Rank:

6 years ago
David.Smith.22072 predicted that NVCN for 2018-03-19 is going $0.100 (-25.15%)

Rank:

6 years ago
Luxbu predicted that NVCN for 2018-03-16 is going $0.0670 (-39.69%)

Rank:
Click to get the best stock tips daily for free!

About Neovasc Inc.

Neovasc. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incor... NVCN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT